1. Home
  2. RCKT vs NATH Comparison

RCKT vs NATH Comparison

Compare RCKT & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.87

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.87

Market Cap

411.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
NATH
Founded
1999
1916
Country
United States
United States
Employees
202
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
534.2M
411.8M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RCKT
NATH
Price
$4.87
$100.87
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$29.65
N/A
AVG Volume (30 Days)
2.9M
32.5K
Earning Date
01-01-0001
05-22-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
22.29
EPS
N/A
4.17
Revenue
N/A
$104,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$97.68
N/A
P/E Ratio
N/A
$24.07
Revenue Growth
N/A
7.81
52 Week Low
$2.19
$88.00
52 Week High
$8.80
$118.32

Technical Indicators

Market Signals
Indicator
RCKT
NATH
Relative Strength Index (RSI) 58.97 57.80
Support Level $2.99 $100.25
Resistance Level $5.34 $101.86
Average True Range (ATR) 0.38 0.43
MACD -0.00 -0.14
Stochastic Oscillator 51.16 81.58

Price Performance

Historical Comparison
RCKT
NATH

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: